Iterum Therapeutics Plc (ITRM) Tops Q4 EPS by 10c

Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q4 EPS of ($0.12), $0.10 better than the analyst estimate of ($0.22).

For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.

You May Also Be Interested In

• Evercore ISI Reiterates Underperform Rating on Lennar (LEN)
• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Legend Biotech reports early clinical trial results for LB2501 therapy